662
Views
0
CrossRef citations to date
0
Altmetric
Pharmacology and Nephro-Oncology

Chemotherapy plus therapeutic plasmapheresis with 4% human albumin solution in multiple myeloma patients with acute kidney injury: a prospective, open-label, proof-of-concept study

, , , , , , , , , , , , , , & show all
Article: 2356708 | Received 16 Mar 2023, Accepted 13 May 2024, Published online: 27 May 2024